Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jun 5;32(6):990-1005.e8.
doi: 10.1016/j.stem.2025.04.010. Epub 2025 May 21.

HBO1 functions as an epigenetic barrier to hepatocyte plasticity and reprogramming during liver injury

Affiliations

HBO1 functions as an epigenetic barrier to hepatocyte plasticity and reprogramming during liver injury

Wei-Chien Yuan et al. Cell Stem Cell. .

Abstract

Hepatocytes can reprogram into biliary epithelial cells (BECs) during liver injury, but the underlying epigenetic mechanisms remain poorly understood. Here, we define the chromatin dynamics of this process using single-cell ATAC-seq and identify YAP/TEAD activation as a key driver of chromatin remodeling. An in vivo CRISPR screen highlights the histone acetyltransferase HBO1 as a critical barrier to reprogramming. HBO1 is recruited by YAP to target loci, where it promotes histone H3 lysine 14 acetylation (H3K14ac) and engages the chromatin reader zinc-finger MYND-type containing 8 (ZMYND8) to suppress YAP/TEAD-driven transcription. Loss of HBO1 accelerates chromatin remodeling, enhances YAP binding, and enables a more complete hepatocyte-to-BEC transition. Our findings position HBO1 as an epigenetic brake that restrains YAP-mediated reprogramming, suggesting that targeting HBO1 may enhance hepatocyte plasticity for liver regeneration.

Keywords: HBO1; Hippo-YAP; epigenetic regulation; hepatocyte reprogramming; in vivo CRISPR screen.

PubMed Disclaimer

Conflict of interest statement

Declaration of interests The authors declare no competing financial interests.

References

    1. Nord AS, Blow MJ, Attanasio C, Akiyama JA, Holt A, Hosseini R, Phouanenavong S, Plajzer-Frick I, Shoukry M, Afzal V, et al. (2013). Rapid and pervasive changes in genome-wide enhancer usage during mammalian development. Cell 155, 1521–1531. 10.1016/j.cell.2013.11.033. - DOI - PMC - PubMed
    1. Stergachis AB, Neph S, Reynolds A, Humbert R, Miller B, Paige SL, Vernot B, Cheng JB, Thurman RE, Sandstrom R, et al. (2013). Developmental fate and cellular maturity encoded in human regulatory DNA landscapes. Cell 154, 888–903. 10.1016/j.cell.2013.07.020. - DOI - PMC - PubMed
    1. Mattout A, and Meshorer E. (2010). Chromatin plasticity and genome organization in pluripotent embryonic stem cells. Curr Opin Cell Biol 22, 334–341. 10.1016/j.ceb.2010.02.001. - DOI - PubMed
    1. Jopling C, Boue S, and Izpisua Belmonte JC (2011). Dedifferentiation, transdifferentiation and reprogramming: three routes to regeneration. Nature reviews. Molecular cell biology 12, 79–89. 10.1038/nrm3043. - DOI - PubMed
    1. Goldman JA, and Poss KD (2020). Gene regulatory programmes of tissue regeneration. Nature reviews. Genetics 21, 511–525. 10.1038/s41576-020-0239-7. - DOI - PMC - PubMed

MeSH terms

LinkOut - more resources